Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics
Phase 1
Completed
- Conditions
- HealthyCystic Fibrosis
- Interventions
- First Posted Date
- 2012-02-23
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- Savara Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT01537666
- Locations
- 🇦🇺
Linear Clinical Research Ltd., Perth, Western Australia, Australia
🇦🇺Mater Adult Hospital, Brisbane, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath